# Evaluate the Safety and Efficacy of Intracoronary Lithotripsy Balloon Catheter and Intracoronary Lithotripsy Apparatus

Study · id `cardio:ct-nct05649488` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05649488](<https://clinicaltrials.gov/study/NCT05649488>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05649488

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 184 participants.

## Technical summary

Registry record NCT05649488. Non-randomized; no masking; primary purpose treatment. Start 2023-02-09 (actual); primary completion 2024-12-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; non-randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 184 participants (planned count; ClinicalTrials.gov record NCT05649488, source copy `cardio:ctgov-nct05649488-2023-04-13`, retrieved 2026-10-26)
- Started: 2023-02-09 (actual) (ClinicalTrials.gov record NCT05649488, source copy `cardio:ctgov-nct05649488-2023-04-13`, retrieved 2026-10-26)
- Primary completion: 2024-12-01 (anticipated) (ClinicalTrials.gov record NCT05649488, source copy `cardio:ctgov-nct05649488-2023-04-13`, retrieved 2026-10-26)
- Completion: 2025-09-22 (anticipated) (ClinicalTrials.gov record NCT05649488, source copy `cardio:ctgov-nct05649488-2023-04-13`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT05649488, source copy `cardio:ctgov-nct05649488-2023-04-13`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05649488-2023-04-13`, retrieved 2026-10-26)

## The registry's words

- Brief title: Evaluate the Safety and Efficacy of Intracoronary Lithotripsy Balloon Catheter and Intracoronary Lithotripsy Apparatus
- Condition: Coronary Artery Disease
- Condition: Intravascular Lithotripsy
- Intervention (Device): Intracoronary lithotripsy balloon catheter and Intracoronary lithotripsy apparatus
- Intervention (Device): Dragonfly Opstar Imaging Catheter
- Lead sponsor: Shanghai Bluesail Boyuan Medical Technology Co., Ltd.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: Shanghai Bluesail Boyuan Medical Technology Co., Ltd. (`cardio:org-shanghai-bluesail-boyuan-medical-technology-co-ltd`)

## Provenance

Content hash: 8f261f7946219475bbfd72c949828aa27dd96d8c8914f1320ed3b4e76aa2d3b4
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
